The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lutetium-177 PSMA radioligand therapy for metastatic castration resistant prostate cancer in Germany: Population-based data with multicenter validation from 2016 to 2020.
 
Luka Flegar
No Relationships to Disclose
 
Smita George Thoduka
No Relationships to Disclose
 
Damiano Librizzi
No Relationships to Disclose
 
Markus Luster
No Relationships to Disclose
 
Aristeidis Zacharis
No Relationships to Disclose
 
Hendrik Heers
No Relationships to Disclose
 
Nicole Eisenmenger
No Relationships to Disclose
 
Hojjat Ahmadzadehfar
No Relationships to Disclose
 
Matthias Eiber
Consulting or Advisory Role - Blue Earth Diagnostics
Research Funding - ABX Advanced biochemical compounds; Blue Earth Diagnostics; Siemens
Patents, Royalties, Other Intellectual Property - patent application for rhPSMA
Travel, Accommodations, Expenses - Bayer Schering Pharma
 
Wolfgang A Weber
Consulting or Advisory Role - Blue Earth Diagnostics (Inst); ITG (Inst); Pentixapharm (Inst)
Research Funding - Blue Earth Diagnostics (Inst); ITG (Inst)
Patents, Royalties, Other Intellectual Property - Patent for PARP imaging agent
Travel, Accommodations, Expenses - Blue Earth Diagnostics; Pentixapharm
 
Christer Groeben
No Relationships to Disclose
 
Johannes Huber
No Relationships to Disclose